Why COMPASS Pathways plc (CMPS) Draws Both Optimism and Caution

COMPASS Pathways plc (NASDAQ:CMPS) is among the Best Get Rich Fast Stocks to Buy Right Now. As of December 24, COMPASS Pathways plc (NASDAQ:CMPS) has a ‘Buy’ or equivalent rating from the majority of the analysts covering the stock. With a target price range of $8 to $40, the median price target of $15 translates to an upside potential of 119.14% from the current price.

On December 17, Gavin Clark-Gartner, an analyst at Evercore ISI, reaffirmed a ‘Hold’ rating on COMPASS Pathways plc (NASDAQ:CMPS), keeping a price target of $8. This reflects an upside potential of 16.87% from the current level.

Geo Group (GEO) Falls 11.46% on Lower Earnings Outlook

Photo by Anthony Tran on Unsplash

Earlier, on December 9, Oppenheimer upgraded COMPASS Pathways plc (NASDAQ:CMPS) to Outperform from Perform, with a price target of $15. This revision is driven by the prospects of the company’s psilocybin therapy for treatment-resistant depression. The firm believes that the company’s psilocybin-based therapy, COMP360, is well-positioned to lead the transformation of psychedelic medicine in neuropsychiatry.

Oppenheimer sees a record sales opportunity of nearly $1.5 billion for the treatment, which appears substantial considering the company’s current market capitalization of over $600 million. The research firm also noted that COMPASS Pathways plc (NASDAQ:CMPS) is poised to advance beyond key upcoming catalysts, given its strong financial footing with an adequate cash runway, and expects it to benefit from an early-mover advantage in the psychedelics space.

COMPASS Pathways plc (NASDAQ:CMPS) is a London-based biotechnology company emphasizing mental health. Founded in 2020, the company is committed to mental well-being.

While we acknowledge the potential of CMPS to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CMPS and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None.